Epirubicin: a phase II study in recurrent small-cell lung cancer

Mark Rosenthal, Richard Kefford, Derek Raghavan, Robin Stuart-Harris*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Epirubicin: a phase II study in recurrent small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry